IN-VIVO AND IN-VITRO CORRELATION FOR DELAYED-RELEASE BEHAVIOR OF A MOLSIDOMINE O-CARBOXYMETHYL-O-ETHYL-BETA-CYCLODEXTRIN COMPLEX IN GASTRIC ACIDITY-CONTROLLED DOGS

被引:17
作者
HORIKAWA, T [1 ]
HIRAYAMA, F [1 ]
UEKAMA, K [1 ]
机构
[1] KUMAMOTO UNIV,FAC PHARMACEUT SCI,KUMAMOTO 862,JAPAN
关键词
D O I
10.1111/j.2042-7158.1995.tb05763.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The in-vivo absorption behaviour of molsidomine from the delayed-release tablets of an O-carboxy-methyl-O-ethyl-beta-cyclodextrin complex was investigated using gastric acidity-controlled dogs under fasted and non-fasted conditions. The in-vitro release profiles were generated by changing the pH of the dissolution medium at different rotation paddle speeds, The absorptivity of molsidomine in the high acidity dog was correlated with the pH-changed release profile (pH 1.2 to 7.0 after 2 h), whereas that in the low acidity dog was correlated with the release profile at a constant pH of 7.0. The absorption in fasted dogs was well correlated with the invitro release at the low-rotation paddle speed (< 5 rev min(-1)), whereas that in the non-fasted dogs was correlated with that of high rotation (100 rev min(-1)). The present results suggested that the in-vivo delayed-release behaviour of the complex is predictable from the in-vitro release profiles generated using pH-variable dissolution testing apparatus at different rotation speeds of the paddle.
引用
收藏
页码:124 / 127
页数:4
相关论文
共 16 条
[1]  
ADACHI H, 1992, CHEM PHARM BULL, V40, P1586
[2]  
[Anonymous], 1991, NEW TRENDS CYCLODEXT
[3]   RELEASE CONTROL OF THEOPHYLLINE BY BETA-CYCLODEXTRIN DERIVATIVES - HYBRIDIZING EFFECT OF HYDROPHILIC, HYDROPHOBIC AND IONIZABLE BETA-CYCLODEXTRIN COMPLEXES [J].
HORIUCHI, Y ;
ABE, K ;
HIRAYAMA, F ;
UEKAMA, K .
JOURNAL OF CONTROLLED RELEASE, 1991, 15 (02) :177-183
[4]   IMPROVEMENT OF STABILITY AND BIOAVAILABILITY OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL (HCFU) BY O-CARBOXYMETHYL-O-ETHYL-BETA-CYCLODEXTRIN [J].
HORIUCHI, Y ;
HIRAYAMA, F ;
UEKAMA, K .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1991, 111 (10) :592-599
[5]   SOLUBILIZATION OF DRUGS BY MODIFIED BETA-CYCLODEXTRINS [J].
MULLER, BW ;
BRAUNS, U .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 26 (1-2) :77-88
[6]   AMORPHOUS WATER-SOLUBLE DERIVATIVES OF CYCLODEXTRINS - NONTOXIC DISSOLUTION ENHANCING EXCIPIENTS [J].
PITHA, J ;
PITHA, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (09) :987-990
[7]   INVITRO AND INVIVO TESTING AND CORRELATION FOR ORAL CONTROLLED MODIFIED-RELEASE DOSAGE FORMS [J].
SKELLY, JP ;
AMIDON, GL ;
BARR, WH ;
BENET, LZ ;
CARTER, JE ;
ROBINSON, JR ;
SHAH, VP ;
YACOBI, A .
PHARMACEUTICAL RESEARCH, 1990, 7 (09) :975-982
[8]  
Szejtli J., 1988, CYCLODEXTRIN TECHNOL
[9]   BIOAVAILABILITY OF HYDROXYCHLOROQUINE TABLETS ASSESSED WITH DECONVOLUTION TECHNIQUES [J].
TETT, SE ;
CUTLER, DJ ;
DAY, RO .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (02) :155-159
[10]  
UEKAMA K, 1987, CRIT REV THER DRUG, V3, P1